PLEASANTON, CA--(Marketwire - April 07, 2010) - IntegenX, Inc. (formerly Microchip Biotechnologies, Inc.), today announced the grand opening of its new corporate headquarters and high-tech manufacturing facility at 5720 Stoneridge Drive, Pleasanton, California, in the Hacienda Business Park. In attendance at the event’s ribbon-cutting ceremony and open-house celebration were the company’s executive staff, employees and their family members, investors, board members, representatives of the Pleasanton Chamber of Commerce, Pleasanton City Mayor Jennifer Hosterman, and Congressman Jerry McNerney, serving California’s 11th district.
Having out-grown their previous location in nearby Dublin, California, IntegenX again selected the Tri-Valley area as their headquarters. The new location features a microfabrication facility, custom-designed laboratories for the company’s research and development, and manufacturing space for commercial operations. IntegenX will use the in-house microfabrication facility to rapidly prototype microdevices for use in its fully integrated systems supplied to life science research laboratories worldwide.
“As we grew out of the old space, we were determined to preserve the advantages of keeping everyone together in one building and in the Tri-Valley where we can attract skilled biologists and engineers to invent and develop the next generation of life science tools,” said Stevan Jovanovich, PhD, President and Chief Executive Officer at IntegenX. “This new location provides a more collaborative environment where we can discuss ideas easily and solve problems quickly, and the space and facilities we need to ramp up operations.”
Congressman Jerry McNerney added, “I’m pleased to congratulate IntegenX on the opening of their new headquarters in Pleasanton. It’s good news to see IntegenX growing and expanding in the Tri-Valley. I look forward to their continued contribution to our community.”
About IntegenX™, Inc.
IntegenX, Inc. headquartered in Pleasanton, CA, is a privately-held company that designs, manufactures and markets automated DNA and RNA-based sample preparation systems for life sciences, applied sciences, and diagnostics markets. The company’s products eliminate the most acute pain points affecting widely adopted laboratory workflows in genomics. Its first commercial product, the Apollo 100 System, is available today and integrates the company’s patented MOVe™ valve technology into a robotic platform that prepares DNA for Sequencing. Future IntegenX products will address the workflows in next-generation sequencing library preparation and human DNA Identification. The company’s expertise and intellectual property is based on a next-generation fluidics technology platform that integrates advanced fluidics and analytical capabilities to produce sample-to-answer performance for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, as well as molecular diagnostics applications. Details about IntegenX, its technologies and products can be found at www.integenX.com.
Contact:
Howard D. Goldstein
IntegenX, Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94568
(925) 701-3481
howardg@integenX.com